Effects of Emicizumab Treatment in Patients With Hemophilia A
NCT07190118 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2025-09-24
Summary
The aim of our study is to investigate the effects of emicizumab treatment on the musculoskeletal system in children with hemophilia A.
Conditions
- Hemophilia A
- Musculoskeletal Assessment
- Musculoskeletal Abnormalities
Sponsors & Collaborators
-
Hasan Kalyoncu University
lead OTHER
Principal Investigators
-
Tuğba GÖNEN, Asisst. Prof. Dr. · Hasan Kalyoncu University
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-30
- Primary Completion
- 2025-11-10
- Completion
- 2026-02-10
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Multidisciplinary Evaluation of Patients With Hemophilia
NCT02198430 ·Status: COMPLETED
-
Efficacy, Safety, and Pharmacokinetic Study of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Participants
NCT03315455 ·Status: COMPLETED ·Phase: PHASE3
-
COVID-19 Quarantine on Musculoskeletal Status in Hemophilia
NCT04491318 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without Inhibitors
NCT04431726 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks in Participants With Hemophilia A
NCT03020160 ·Status: COMPLETED ·Phase: PHASE3
-
Transcultural Multidisciplinary Evaluation of Patients With Hemophili
NCT02199639 ·Status: UNKNOWN
-
Outcomes of Prophylaxis With Emicizumab in Children With Severe Hemophilia A in Ivory Coast
NCT05279924 ·Status: COMPLETED ·Phase: NA
-
Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
NCT05022459 ·Status: RECRUITING
-
Emicizumab in Patients With Acquired Hemophilia A
NCT05345197 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Multidimensional Assessment of Chronic Pain in Severe Haemophilia A
NCT07096349 ·Status: RECRUITING
-
A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors
NCT04158648 ·Status: COMPLETED ·Phase: PHASE3
-
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors
NCT04083781 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhibitors
NCT03191799 ·Status: COMPLETED ·Phase: PHASE3
-
An Exploration of the Impact of Emicizumab on the Lives of People With Haemophilia and Inhibitors and Their Families
NCT04723693 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors
NCT02622321 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Emicizumab Prophylaxis in Participants With Hemophilia A With or Without Inhibitors Undergoing Minor Surgical Procedures
NCT03361137 ·Status: TERMINATED ·Phase: PHASE4
-
Low Dose Emicizumab vs Low Dose Factor VIII in Prophylaxis in Hemophilia A Patients
NCT06938659 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors
NCT02795767 ·Status: COMPLETED ·Phase: PHASE3
-
Satisfaction Regarding the Dispensing of Emicizumab (HEMLIBRA®) for Patients With Haemophilia A in France
NCT05450640 ·Status: COMPLETED
-
Sonography and Haemophilia
NCT04550988 ·Status: UNKNOWN
-
Data Registry in Chinese Hemophilia A and B Patients
NCT07101224 ·Status: COMPLETED
-
Hemlibra in Mild Hemophilia A
NCT04567511 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis
NCT05181618 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors
NCT05135559 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3